US Industrial Production m/m* Actual : 0.6% Forecast: 0.3% Prev.: 0.9% Impact : Negative for Precious metals #FinancialNews #StockMarket #Investment #Trading US Industrial Production m/m* Actual : 0.6% Forecast: 0.3% Prev.: 0.9% Impact : Negative for Precious metals #FinancialNews #StockMarket #Investment #Trading

Posted on by Raj Gaurav Rai

US Industrial Production m/m*
Actual : 0.6%
Forecast: 0.3%
Prev.: 0.9%
Impact : Negative for Precious metals #FinancialNews #StockMarket #Investment #Trading US Industrial Production m/m*
Actual : 0.6%
Forecast: 0.3%
Prev.: 0.9%
Impact : Negative for Precious metals #FinancialNews #StockMarket #Investment #Trading

Please follow and like us:
fb-share-icon
Tweet
Pin Share

Related Posts

US Economic Event• Core PPI (MoM) (Sep): Actual 0.2% Forecast 0.2% Previous 0.3%• Core PPI (YoY) (Sep): Actual 2.8% Forecast 2.7% Previous 2.6%• PPI (MoM) (Sep): Actual 0.0% Forecast 0.1% Previous 0.2%• PPI (YoY) (Sep): Actual 1.8% Forecast 1.6% Previous 1.9% US Economic Event• Core PPI (MoM) (Sep): Actual 0.2% Forecast 0.2% Previous 0.3%• Core PPI (YoY) (Sep): Actual 2.8% Forecast 2.7% Previous 2.6%• PPI (MoM) (Sep): Actual 0.0% Forecast 0.1% Previous 0.2%• PPI (YoY) (Sep): Actual 1.8% Forecast 1.6% Previous 1.9%

US Economic Event • Core PPI (MoM) (Sep): Actual 0.2% Forecast 0.2% Previous 0.3%• Core PPI (YoY) (Sep): Actual 2.8% Forecast 2.7% Previous 2.6% • […]

Dr. Reddys-USA Subsidiary, entered a license agreement with Ingenus Pharmaceuticals, LLC for exclusive rights to commercialize Cyclophosphamide Injection RTD in the U.S.-Sales of the product for the past 12 months ended March 2024 were $51.8 million Dr. Reddys-USA Subsidiary, entered a license agreement with Ingenus Pharmaceuticals, LLC for exclusive rights to commercialize Cyclophosphamide Injection RTD in the U.S.-Sales of the product for the past 12 months ended March 2024 were $51.8 million

Dr. Reddys -USA Subsidiary, entered a license agreement with Ingenus Pharmaceuticals, LLC for exclusive rights to commercialize Cyclophosphamide Injection RTD in the U.S. -Sales of […]